Hypoxic conditioned medium from mesenchymal stem cells promotes lymphangiogenesis by regulation of mitochondrial-related proteins
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- STEM CELL RESEARCH & THERAPY7 · 2016
- 피인용
- Web of Science 19
- JCR IF
- JCR 2015 4.504
- ISSN
- 1757-6512
저자
- Lee, Chang Youn제1저자Department of Integrated Omics for Biomedical Sciences, Graduate School, Yonsei University, Seoul, South Korea
- Kang, Jin YoungDepartment of Rehabilitation Medicine, National Traffic Injury Rehabilitation Hospital, College of Medicine, Catholic University of Korea, Yangpyeong-gun, South Korea
- Lim, SoyeonInstitute for Bio-Medical Convergence, College of Medicine, Catholic Kwandong University, Gangneung-si, South Korea
- Ham, OnjuCatholic Kwandong University, International St. Mary's Hospital, Incheon Metropolitan City, South Korea
- 장우철교신저자Department of Biology Education, College of Education, Pusan National University, Busan, South Korea
- Jang, Dae-HyunDepartment of Rehabilitation Medicine, Incheon St. Mary's Hospital, College of Medicine, Catholic University of Korea, Bupyeong-gu, Incheon, South Korea
초록
Background: Recently, cell-based therapeutic lymphangiogenesis has emerged and provided hope for lymphatic regeneration. Previous studies have demonstrated that secretomes of mesenchymal stem cells (MSCs) facilitate the regeneration of various damaged tissues. This study was conducted to evaluate the lymphangiogenic potential of hypoxic conditioned media (HCM) from MSCs. Methods: To investigate the effects of MSC-secreted factors in starved human lymphatic endothelial cells (hLEC), hLECs were treated with endothelial basal medium (EBM)-2 (control), normoxic conditioned media (NCM), or HCM in vitro and in vivo. Results: MSCs expressed lymphangiogenic factors including EGF, FGF2, HGF, IGF-1, and VEGF-A and -C. hLECs were treated with each medium. hLEC proliferation, migration, and tube formation were improved under HCM compared with NCM. Moreover, expression of mitochondrial-related factors, MFN1and 2, were improved in HCM-treated hLECs. Lymphedema mice injected with HCM showed markedly decreased lymphedema via increased lymphatic vessel formation when compared with EBM-2- or NCM-treated mice. Conclusions: This study suggested that HCM from MSCs contain high levels of secreted lymphangiogenic factors and promote lymphangiogenesis by regulating mitochondrial-related factors. Thus, treatment with HCM may be a therapeutic strategy for lymphedema.
키워드
Hypoxic conditioned mediaMesenchymal stem cellsMitochondrial-related proteinLymphangiogenesisLymphatic endothelial cellsADIPOSE STROMAL CELLSGROWTH-FACTOR-CENDOTHELIAL-CELLSIN-VIVOTHERAPEUTIC LYMPHANGIOGENESISLYMPHATIC VESSELSTISSUEREGENERATIONLYMPHEDEMAACTIVATION
식별자
- WoS UID
- 000371782300001



로그인
연구물 목록으로